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ABSTRACT 
Objective: The objective of the work was to validate the structural binding affinity of Squalene with the envelope protein of Dengue virus by means 
of molecular simulations. 
Methods: Three-dimensional (3D) structure of dengue 2 virus envelope protein was retrieved from Protein Data Bank PDB and Squalene 
compound from the ZINC database. Molecular docking between the E protein and Squalene were carried out by means of Auto Dock 4.2.  
Results: Based on the study, it was observed that the binding/docking energy for the complex structure was calculated to be-5.55 kcal/mol. Critical 
residues to interact with E protein were scrutinized by analyzing the interface of the complex within 4 Å proximity. Residues such as Thr 48, Glu49, 
Ala 50, Val 130, Leu 135, Ser 186, Pro 187, Thr 189, Gly 190, Leu 191, Phe 193, Leu 198, Leu 207, Thr 268, Phe 279, Thr 280, Gly 281, His 282 and 
Leu 283 were found to be non-covalently located around the squalene.  
Conclusion: Scopes to design de novo anti-viral compounds to the dengue viruses by using squalene as a new class of template structure have also 
been concisely brought into fore. 
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In general, diseases can be defined as disorders of physiological 
functions in human beings. The diseases can be broadly classified 
into infectious and non-infectious diseases: infectious diseases are 
caused by pathogenic microorganisms like bacteria, viruses, fungi 
and the diseases can be spread from one person to another directly 
or indirectly; non-infectious diseases (such as cancer, diabetes and 
etc.) are generally caused by genetics, molecular dysfunctions, 
environmental factors or nutritional abnormalities [1]. Of the 
various infectious diseases, neglected tropical diseases (NTDs) 
comprise a group of diseases such as Buruli ulcer, Lymphatic 
filariasis, Chagas disease, Onchocerciasis, Dengue fever, 
Schistosomiasis, Dracunculiasis (guinea-worm disease) Soil-
transmitted helminthiasis (ascariasis), Human African 
trypanosomiasis, Hookworm infections, Trichuriasis, Leishmaniasis, 
Trachoma, Leprosy and Zoonotic diseases and the NTDs are 
prevalent in developed and as well as developing countries 
according to the World Health Organization (WHO) [2]. A recent 
survey suggests that more than 1 billion people worldwide are 
affected by the NTDs and the people suffer from life-long physical 
pain and social stigmatization. Etiology of the NTDs is chiefly 
attributed to the unhygienic lifestyle and substandard sanitation 
practices [3]. 
Dengue is one of the NTDs and the disease is originated from the 
dengue viruses belong to Flavivirus, which is the genus of the family 
Flaviviridae. The dengue viruses cause Encephalitis in a human being 
and the people with encephalitis suffer from fever, seizures, severe 
headache, photophobia, cough and drowsiness [4]. There are no 
specific anti-viral drugs and vaccination to treat the dengue disease 
to date, though drugs such as ribavirin, acyclovir and EICAR are 
being used to treat the infections at the present juncture [5]. The 
dengue viruses are transmitted to human beings by arthropods such 
as Aedes aegypti and Aedes albopictus and outbreak of the diseases is 
severe especially in monsoon season of tropical countries exercising 
substandard sanitation [6].  
The dengue virus consists of a single-stranded RNA encoding three 
structural proteins (capsid protein (C), pre-membrane protein 
(prM), and envelope protein (E)) and seven non-structural proteins 
(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [7]. The viral RNA is 
encapsulated by the structural proteins C and E and the protein E 
play essential roles in fusing the viral membrane with host 
membrane under acidic environments [8]. It has been substantiated 
that hydrophobic residues of beta-hairpin of the protein E 
comprising of residues from 268 to 280 are crucial for the protein E 
conformational changes leading to the fusion processes [9]. In this 
background, a few studies reported in the literature have shown that 
small chemical molecules that are targeting to interact with the 
hydrophobic residues present in the groove of the envelope protein 
E would pave a way to develop anti-viral chemical compounds 
against the dengue viruses.  
In the present study, we have examined specific structural 
interactions between the E protein and triterpenoid squalene, which 
has been recently proven to exhibit larvicidal activity against Aedes 
aegypti [10]. Outputs of the study demonstrated that the squalene is 
a promising prototype for developing a novel class of antiviral 
compounds against the dengue viruses.  
MATERIALS AND METHODS 
Structural analyses and molecular docking 
Three-dimensional (3D) structure of dengue 2 virus envelope 
protein bound with n-octyl-beta-D glucoside was retrieved from 
Protein Data Bank (PDB, https://www. rcsb. org/) and PDB ID of the 
protein is 1OKE, which was dimer in the crystal state. The 
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monomeric form of the protein consisting of 394 standard amino 
acids (ranging from 281 to 674) and also bereft of the ligand and 
water molecules were prepared, energy minimized and used for the 
molecular docking studies of the present studies. The 3D structure of 
the small chemical molecule, squalene (C30H50
Molecular dockings between the envelope protein and the squalene 
were carried out by means of Auto Dock 4.2 [12] wherein the 
protein and the ligand was kept as rigid and flexible, respectively. 
The docking parameters such as genetic runs, populations, energy 
evaluations, generations, the rate of gene mutation and rate of cross-
over were set as 100, 500, 25,000,000, 27,000, 0.02 and 0.8, 
respectively. Grid dimensions of 84 x 88 x 92 Å were used to cover 
the entire cavity (which were present on core region of the protein) 
of the envelope protein and as well the n-octyl-beta-D-glucoside 
binding groove of the protein.  
, ZINC 06845904), was 
retrieved in mol2 structural format from the ZINC database [11]. 
After successful completion of the docking processes, the docked 
conformations of the ligands were clustered with a tolerance limit of 
1 Å. Based on the cluster patterns and docking energies, a 
representative protein-ligand complex was generated and the 
complex structure was further used in order to scrutinize various 
non-bonding network interactions between the molecules. The 
structural interactions between the envelope protein and the 
squalene of the docking complex structure were viewed, analyzed 
and represented using molecular visualization tool PyMol 
(http://www.pymol.org). 
RESULTS AND DISCUSSION 
Infections due to dengue diseases are a serious medical problem in 
most tropical countries. To date, there are no specific medications to 
mitigate or to eradicate the diseases. There are reports in the 
literature demonstrating quests to identify lead molecules that are 
capable of retarding the functions of either structural or non-
structural proteins of the dengue viruses [13]. In this context, it is 
worthy of mentioning that a few small molecular inhibitors to the 
non-structural proteins of the dengue viruses have been reported as 
probed by a variety of computational strategies. For instances, 
Sivakumar et al. [14] designed a few novel ribavirin triphosphate 
analogs as antagonists to NS5-methyltransferase of dengue viruses 
by means of an array of in silico strategies and the lead compounds 
may eventually be developed as anti-viral drugs against the dengue 
viruses. Moreover, the research studies also rationalized that the 
novel ribavirin analogs presumably may not cause hemolytic anemia 
to the patients supposed to administrate them as the compounds 
showed weak affinities towards the JAK2 enzyme playing essential 
roles in erythropoiesis. Qamar et al. [15] postulate through a 
computational approach that flavanoids (Deoxycalyxin A, 3,5,7,3',4'-
pentahydroxyflavonol-3-O-beta-D-galactopyranoside, (3R)-3',8-
Dihydroxyvestitol, Sanggenon O, Epigallocatechin gallate and 
Chamaejasmine) inhibited the NS1 (by blocking through the 
Asparagin 130 glycosylation site), an important regulatory element 
in the replication processes of dengue viruses. Ariza et al. [16] 
showed that molecular dockings between curcumin and RdRp 
domain of the NS5 protein, also a key element in the viral 
replication, with a binding energy of-6.2 Kcal/mol. Rufaidah Othman 
et al. [17] demonstrated the binding interactions of antibiotics 
pinostrobin (with binding energy of-5.33 Kcal/mol), doxycycline 
(with binding energy of-5.15 Kcal/mol), 4-hydroxypanduratin A 
(with binding energy of-4.45 Kcal/mol), meclofenamic acid (with 
binding energy of-3.64 Kcal/mol) androlitetracycline (with binding 
energy of-3.21 Kcal/mol) against NS2B-NS3 proteases of dengue 
viruses. Nasution Aini and Tambunan [18] listed out 18 promising 
leads to chemotherapy treatments of the dengue diseases based on 
the comprehensive analyses of molecular docking complexes of 308 
diverse molecules bound with NS2B-NS3 proteases of the dengue 
viruses. 
E protein of dengue virus is a key regulatory element in the fusion 
process with the host cells. The fusion process involves host entry and 
attachment; internalization of the viral genome in the host is 
accomplished by receptor-mediated, clathrin-dependent endocytosis 
[19]. Hence, the non-structural proteins that are playing essential 
roles in integrating virus genome with the host organisms would 
also act as druggable targets. In other words, preventing interactions 
between the surface proteins of dengue virus with membrane 
proteins of host cells is also an attracting strategy in the 
chemotherapy treatments of dengue diseases. There are a few 
limited studies that have been conducted on the molecular 
interactions between E protein and various compounds derived 
from plant sources by using experimental and as well as 
computational approaches. For instance, Asif Mir et al. [20] 
performed molecular simulation studies on E protein with a few 
flavonoids (baicalein, fisetin, naringenin, quercetin) and showed that 
flavonoids could possible interrupt the fusion process by inhibiting 
the hydrophobic residues present in the groove of the envelope 
protein E. The binding affinities of the ligands baicalein, naringenin, 
fisetinquercetin were reported to be-8.5 Kcal/mol,-8.1 kcal/mol,-7.3 
kcal/mol and-7.1 kcal/mol, respectively, suggesting the structural 
interactions between the E protein and the flavonoids are highly 
specific in nature.  
As discussed above and as well numerous reports in the literature, 
primary validation of leads/drugs through in silico approach against 
various infectious diseases is popularizing among research 
fraternity due to the feasibility of the drug discovery process [21]. 
Currently, experiments pertaining to a high-throughput virtual 
screening of phytochemicals against target sites/molecules of 
infectious agents have a profound significance in the development of 
lead compounds [22]. In the present study, we have examined specific 
structural interactions between the triterpenoid squalene and protein 
E of the dengue virus by means of molecular docking methods. The 
squalene is a triterpenoid compound found in latex and resins of 
plants; functionally the squalene bears defense mechanism against 
pathogens. As reported in the literature, squalene has a therapeutic 
regimen such as antimicrobial, anticancer, antioxidant, chemo-
preventive, gastropreventive and hepatoprotective, pesticide, anti-
tumor and sunscreen properties [23].  
In the recent reports of the research group [10], the effects of latex 
extract from E. antiquorum on the various stages of instar larvae of 
A. aegypti and C. quinquefasciatus have been examined by using 
systematic experimental methods. Of the different solvent extracts 
of latex, the chloroform extract depicted remarkable growth 
inhibitory activity against different instar larvae of A. aegypti and C. 
quinquefasciatus vis-à-vis to other solvent extracts of latex used in 
the studies. The LC50 values of the chloroform extract against the 
larval stages of II, III and IV of A. aegypti were found to be 68.7, 82.2 
and 90.5 (ppm) respectively; similarly, The LC50
The physicochemical properties of the squalene and the active site of 
the dengue virus envelope protein was found to be compatible with 
each other and the data provided the cue for studying interactions 
between the two molecules. The active site of the envelope protein is 
highly hydrophobic in nature and the protein is essential to fuse the 
viruses with host systems. Interestingly, the squalene depicted 
structural and functional complementary features to be 
accommodated in the active site cavity of the envelope protein. The 
overall three-dimensional conformations of the squalene and 
envelop protein are depicted in fig. 1 in sticks and surface models, 
respectively. The molecular interactions between the squalene and 
the envelope protein were examined using AutoDock 4.2 docking 
tool as described in the method section. Overall binding mode 
between the squalene and envelop protein, as simulated from the 
molecular docking tool, is illustrated in the fig. 2 and the 
binding/docking energy for the complex structure was calculated to 
be-5.55 kcal/mol. Crucial residues of the envelope protein to 
interact with the squalene were scrutinized by analyzing the 
 values of the 
chloroform extract against the larval stages of II, III and IV of C. 
quinquefasciatus were found to be 70.0, 72.24 and 68.9 (ppm), 
respectively. The chloroform extract was then subjected to GC-MS 
analysis in order to understand the phytochemical composition of 
the extract and the data suggested that squalene is the abundant 
phytochemical accounting about 18% (w/w) of the dry extract. 
Taken together, the anti-mosquitocidal activity of the latex 
chloroform extract of E. antiquorum could be attributed to the 
presence of squalene in the extract. However, the mechanism by 
which the squalene function as the anti-mosquitocidal activity is left 
unaddressed to date to the best of our knowledge.  
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interface of the complex within 4 Å proximity. Residues such as Thr 
48, Glu49, Ala 50, Val 130, Leu 135, Ser 186, Pro 187, Thr 189, Gly 
190, Leu 191, Phe 193, Leu 198, Leu 207, Thr 268, Phe 279, Thr 280, 
Gly 281, His 282 and Leu 283 were found to be non-covalently 
located around the squalene. The comprehensive analyses of the 
complex at overall molecular and as well at residue level suggested 
the squalene could be fully accommodated in the hydrophobic cavity 
located in the central part of the envelope protein. Meanwhile, it 
would be favorable to confirm the in silico rationalization of the 
specificities brought out into fore herein for the binding interactions 
between the squalene and the envelope protein at residue level 
resolution through experimental evidence in near future. 
 
 
Fig. 1: The three-dimensional structures of A) Squaleen and B) 
Envelop protein of dengue virus are depicted in sticks and 
surface models, respectively 
 
 
Fig. 2: A) Docked conformation of the squalene and envelop 
protein is depicted in magenta sticks and gray surface models, 
respectively. The inset fig. shows zoomed part of the squalene 
and hydrophobic pocket of the envelop protein 
 
Fig. 2B: Snapshot representing residues of envelop protein present in 
the 4 Å proximity of squalene (stick model in magenta). The Residues 
such as Thr 48, Glu49, Ala 50, Val 130, Leu 135, Ser 186, Pro 187, Thr 
189, Gly 190, Leu 191, Phe 193, Leu 198, Leu 207, Thr 268, Phe 279, 
Thr 280, Gly 281, His 282 and Leu 283 are shown in sticks models 
(hydrogen atoms are excluded for sake of clarity) with carbon, 
nitrogen and oxygen atoms painted as gray, blue and red, respectively.  
CONCLUSION 
In conclusion, the computational analyzes revealed that the squalene 
is capable of strongly to interact on the hydrophobic cavity of the 
dengue virus envelop protein. By binding to the hydrophobic pocket, 
the squalene would presumably inactivate the envelope protein 
playing essential roles in fusing dengue viruses with host organisms. 
Hence, the squalene can be used as a template structure to design 
highly efficient de novo anti-viral compounds against dengue viruses. 
To be brief, in the de novo drug designing, squalene as a seed 
molecule with the defined growing site(s) would be placed on the 
hydrophobic binding groove consisting of putative active site 
residues of the envelope protein and small molecular chemical 
compounds would then be generated by means of ‘grow genetic 
algorithm’. Moreover, the algorithm can also be properly tuned in 
terms of fragment library, toxic library and as well other drug 
designing parameter as required to bring desired drug-likeness 
compounds against dengue viruses in near future. 
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